The acute effects of accelerated repetitive transcranial magnetic stimulation on suicide risk in unipolar depression: Preliminary results

Psychiatria Danubina

Volumn 26, Issue , 2014, Pages 48-52

  Desmyter, Stefanie ^a   Duprat, Romain ^a,b   Baeken, Chris ^a,b,c   Bijttebier, Stijn ^b   Van Heeringen, Kees ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Accelerated theta burst stimulation; Major depressive disorder; repetitive Transcranial Magnetic Stimulation; Suicide ideation; Treatment resistance

Indexed keywords

ACCELERATED INTERMITTENT THETA BURST STIMULATION; ADULT; BECK SCALE OF SUICIDAL IDEATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NERVE STIMULATOR; PLACEBO EFFECT; PREFRONTAL CORTEX; PSYCHIATRIC TREATMENT; RANDOMIZED CONTROLLED TRIAL; REPEAT PROCEDURE; SHAM PROCEDURE; SUICIDAL IDEATION; THERAPY EFFECT; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84918832015     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Baeken C, Vanderhasselt MA, Remue J, Herremans S, Vanderbruggen N, Zeeuws D et al.: Intensive HF-rTMS treatment in refractory medication-resistant unipolar depressed patients. J Affect Disorders 2013; 151:625-631.
2. Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol 1979; 47:343-52.
3. Bertolote JM, Fleischmann A: A global perspective on the magnitude of suicide mortality. In: D Wasserman and C Wasserman (eds.). Oxford Textbook of Suicidology and Suicide Prevention: a global perspective. Oxford: Oxford University Press. p.91-98, 2009.
4. Di Lazzaro V, Pilato F, Dileone M, Profice P, Oliviero A, Mazzone P, Insola A, Ranieri F, Meglio M, Tonali PA, Rothwell JC: The physiological basis of the effects of intermittent theta burst stimulation of the human motor cortex. J Physiol. 2008; 586:3871-9.
5. Figner B, Knoch D, Johnson EJ, Krosch AR, Lisanby SH, Fehr E, Weber EU: Lateral prefrontal cortex and selfcontrol in intertemporal choice. Nat Neuroxci 2010; 13:538-9.
6. Fitzgerald PB, Hoy K, McQueen S, Maller JJ, Herring S, Segrave R et al.: A randomized trial of rTMS targeted with MRI based neuro-navigation in treatment-resistant depression. Neurop- sychopharmacology 2009; 34:1255-1262.
7. George MS: Transcranial magnetic stimulation for the treatment of depression. Expert Rev Neurother 2010; 10:1761-72.
8. George MS, Raman R, Benedek D, Pelic C, Grammer G, Stokes K et al.: A two-site pilot randomized 3 day trial of high dose left prefrontal repetitive transcranial magnetic stimulation (rTMS) for suicidal inpatients. Brain Stimulation 2014; 7:421-431.
9. Gibbons RD, Brown R, Hur K, Davis JM, Mann JJ: Suicidal thoughts and behavior with antidepressant treatment. Reanalysis of the randomized placebocontrolled studies of fluoxetine and venlafaxine. Arch Gen Psychiatry 2012; 60:80-587.
10. Hadley D, Anderson B, Brockardt J, Arana A, Li X, Nahas Z et al.: Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting. J of ECT 2011; 27, Nr. 1.
11. Hamilton, M: Development of a rating scale for primary depressive illness. Brit J Soc Clin Psych 1967; 6:278-296.
12. Holtzheimer P, McDonald W, Mufti M, Kelley M, Quinn S, Corso G et al.: Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression. Depress Anxiety 2010; 27:960-963.
13. Iovieno N, Papakostas GI: Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis. J Clin Psychiatry 2012; 73:1300-6.
14. Keshtkar M, Ghanizadeh A, Firoozabadi A: Repetitive Transcranial Magnetic Stimulation versus electroconvulsive therapy for the treatment of major depressive disorder, a randomized controlled clinical trial. J of ECT 2011; 27:310-4.
15. Mommaerts JL, Devroey D: The placebo-effect: how the subconscious fits in. Perspect Biol Med 2012; 55:43-58.
16. Rush AJ, Thase ME, Dubé S: Research issues in the study of difficult-to-treat depression. Biol Psychiatry 2003; 53:743-53.
17. Schutter DJ: Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind shamcontrolled designs: a meta-analysis. Psychol Med 2009; 39:65-75.
18. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al.: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 20:22-57.
19. Sher L, Mindes J, Novakovic V: Transcranial magnetic stimulation and the treatment of suicidality. Expert Rev Neurother 2010; 10:1781-1784.
20. Sokero TP1, Melartin TK, Rytsälä HJ, Leskelä US, Lestelä-Mielonen PS, Isometsä ET: Suicidal ideation and attempts among psychiatric patients with major depressive disorder. J Clin Psychiatry 2003; 64:1094-100.
21. Thase ME, Rush AJ: When at first you don't succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry 1997; 58(supp13):23-29.
22. WHO 2012: Public health action for the prevention of suicide: a framework.